McDavid Stilwell - 01 Apr 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Financial Officer
Signature
/s/ McDavid Stilwell
Issuer symbol
CHRS
Transactions as of
01 Apr 2023
Net transactions value
-$23,646
Form type
4
Filing time
04 Apr 2023, 20:56:05 UTC
Previous filing
24 Jan 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $23,646 -3,457 -3.3% $6.84 102,252 01 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
F2 Includes 1,466 shares acquired on May 13, 2022, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.